Obtains Huge Funding of $200M to Commercialize Ultrasound Device
Exo is clearly a brand with the potential to take its plans to new heights. The Ultrasound device will become a regular part of Americans’ travels and there are plans to expand in Asia, Europe and North America. Exo received funding of $200M (USD) from their third round. It’s creative and magical. RA Capital Management was only company to make an impact on this round. Previous investors were able to prevent being duped by trading, and BlackRock and Sands Capital as well as Avidity Partners were present.
The brand was first introduced to the public in 2015. The brand was launched to the market in 2015.
Ultrasound machines can be costly for families. The base machine is priced between $40,000 and $250,000.
Exo’s CEO Akkaraju believes ultrasound is key to making a difference in the future. It is painless and has no side effects.
These companies want to make it easier for doctors to use the technology. One third of Americans are suffering from health issues after the age of 30. The whole process takes less that 10 minutes. This is really creative.